A5021746671- Reproductive Health and Contraception
- Maternal and Perinatal Health Interventions
- Ectopic Pregnancy Diagnosis and Management
- Maternal and fetal healthcare
- Global Maternal and Child Health
- Reproductive Health and Technologies
- Anesthesia and Pain Management
- Assisted Reproductive Technology and Twin Pregnancy
- Maternal Mental Health During Pregnancy and Postpartum
- Adolescent Sexual and Reproductive Health
- Grief, Bereavement, and Mental Health
- Healthcare Policy and Management
- Anesthesia and Sedative Agents
- Gestational Trophoblastic Disease Studies
- Pregnancy and Medication Impact
- Prenatal Substance Exposure Effects
- Library Science and Information Systems
- Female Genital Mutilation/Cutting Issues
- Pregnancy and preeclampsia studies
- Ethics and Legal Issues in Pediatric Healthcare
- Breastfeeding Practices and Influences
- Healthcare professionals’ stress and burnout
- Diversity and Career in Medicine
- Gynecological conditions and treatments
- Health Literacy and Information Accessibility
Planned Parenthood
2016-2025
Brigham and Women's Hospital
2016-2025
Harvard University
2015-2024
The University of Texas Southwestern Medical Center
2022
Tufts Medical Center
2022
Society of Family Planning
2016-2022
University of California, San Francisco
1999-2022
Beth Israel Deaconess Medical Center
2022
University of Hawaiʻi at Mānoa
2022
University of Hawaii System
2022
To estimate whether women receiving daily text-message reminders have increased oral contraceptive pill adherence compared with not reminders.This randomized controlled trial estimated there was an effect of on new users. Pill-taking tracked for 3 months by electronic monitoring device wireless data collection. During the study period, participants assigned intervention received a reminder text message. Eighty-two were randomly to detect 1.6+/-2.0 difference (90% power, 5% alpha, 15%...
OBJECTIVE: To estimate the efficacy and acceptability of medical abortion at 64–70 days from last menstrual period (LMP) to compare it with already proven 57–63 LMP gestational age range. METHODS: This prospective, comparative, open-label trial enrolled 729 women pregnancies 57–70 requesting six U.S. clinics. Medical abortions were managed 200 mg mifepristone 800 micrograms buccal misoprostol sites' service delivery protocols. Follow-up visits occurred 7–14 after mifepristone, an considered...
Importance While population-level data suggest Rh immunoglobulin is unnecessary before 12 weeks’ gestation, clinical evidence limited. Thus, guidelines vary, creating confusion surrounding risks and benefits of testing treatment. As abortion care in traditional settings becomes harder to access, many people are choosing self-manage need know if ancillary blood type necessary. Objective To determine how frequently maternal exposure fetal red cells (fRBCs) exceeds the most conservative...
In Brief OBJECTIVE: To study the efficacy, safety, and acceptability of oral immediately swallowed buccal misoprostol 800 mcg after mifepristone 200 mg for terminating pregnancy through 63 days since last menstrual period (LMP). METHODS: This seven-site randomly assigned 966 women seeking abortions to or 24–36 hours with 7–14-day follow-up. RESULTS: Success rates in groups were 91.3% (389 426) 96.2% (405 421), respectively (P=.003; relative risk [RR] 0.95, 95% confidence interval [CI]...
In Brief OBJECTIVE: To assess possible risk factors, management, and outcomes for women with malpositioned intrauterine contraception devices (IUDs). METHODS: This retrospective case–control study compared 182 IUDs shown by ultrasonography at a single institution from 2003 to 2008 properly positioned IUDs. We evaluated whether insertion 6–9 weeks postpartum, postabortion placement, breastfeeding, type of IUD, pregnancy history, leiomyomas, suspected adenomyosis, indication placement were...
OBJECTIVE: To compare immediate initiation with delayed of medication abortion among patients an undesired pregnancy unknown location. METHODS: This retrospective cohort study used electronic medical record data from the Planned Parenthood League Massachusetts (2014–2019) for who requested a last menstrual period (LMP) 42 days or less and location (no gestational sac) on initial ultrasonogram. Clinicians could initiate mifepristone followed by misoprostol while simultaneously excluding...
In Brief OBJECTIVE: To quantify and compare serum levels uterine effects following vaginal (dry), (moistened), buccal, rectal misoprostol administration. METHODS: Forty women seeking elective abortion between 6 12 6/7 weeks were randomly assigned to receive 400 μg of by one four routes. A 2.5-mm pressure monitoring catheter was placed through the cervix fundus record tone activity during 5-hour observation period. Serum acid measured at 15 30 minutes, then every minutes. RESULTS: The groups...
In Brief OBJECTIVE: Manual vacuum aspiration is an alternative to electric suction curettage for first-trimester elective abortion. Although many studies have demonstrated that manual safer than sharp abortion, only a few directly compared it with curettage. These proved the methods be equally effective and acceptable but were too small adequately compare safety. We immediate complication rates abortions performed by aspiration. METHODS: conducted retrospective cohort analysis of all women...
Men aged 18 to 35 years (n = 1318) completed assessments of perpetration intimate partner violence (IPV), abortion involvement, and conflict regarding decisions seek abortion. IPV was associated with greater involvement by men in pregnancies ending should be considered within family planning services; policies requiring women notify or obtain consent partners before seeking an reconsidered; they may facilitate endangerment coercion such decisions.
In Brief Objective: To compare the efficacy and acceptability of same-day misoprostol overnight laminaria for cervical ripening before early second-trimester surgical abortion. Methods: We performed a randomized, double-blinded, controlled trial comparing 400 μg vaginal misoprostol, given 3–4 hours preoperatively, with abortion among women at 13.0–16.0 weeks gestation (n = 84). The primary outcome was procedure time, sample size based on 95% power to detect difference 4.5 minutes between...
To evaluate the effect of insertion etonogestrel implants with mifepristone compared after abortion on risks medical failure and repeat pregnancy over subsequent 6 months.In a randomized trial, we assigned patients undergoing to receive either (Quickstart group) or (Afterstart group). We followed them for 7 months ascertain outcome, pregnancies, contraception use.Between September 2013 August 2014, enrolled 236 participants in Quickstart group 240 Afterstart group. examine failure, conducted...
To evaluate the effects of timing depot medroxyprogesterone acetate injection on medical abortion outcome and risk repeat pregnancy within subsequent 6 months.In a multinational randomized trial, we assigned women undergoing who wanted to administration either with mifepristone (Quickstart group) or after (Afterstart group). We ascertained outcome, pregnancies, contraception use over 7 months.From August 2013 March 2015, enrolled 461 participants durations 75 days less. Of included in...
How rurality relates to women's abortion decision-making in the United States remains largely unexplored existing literature. The present study relies on qualitative methods analyze rural experiences related pregnancy and pathways services Central Appalachia. This analysis examines narratives from 31 participants who disclosed experiencing an unwanted pregnancy, including those continued terminated a pregnancy. Results suggest that women living communities deal with three phases: (1)...
To evaluate operative time after adjunctive misoprostol or mifepristone compared with overnight osmotic dilators alone for cervical preparation before dilation and evacuation at 16-23 6/7 weeks of gestation.This double-blind, three-arm, multicenter, randomized trial alone, plus 400 micrograms buccal 3 hours preoperatively, 200 mg oral during dilator placement evacuation. Our primary outcome was within two cohorts: 16-18 gestation (N=150) 19-23 (N=150). Three hundred women were required 80%...